✦ LIBER ✦

Intravenous and Subcutaneous Immunoglobulin Replacement: A Two-Way Road. Optimizing Healthcare Quality in Patients with Primary Immunodeficiencies

✍ Scribed by Soler-Palacín, Pere; Gasó-Gago, Ingrid; Fernández-Polo, Aurora; Martín-Nalda, Andrea; Oliveras, María; Martinez-Cutillas, Julio; Figueras, Concepció

Book ID: 126962143
Publisher: Springer
Year: 2014
Tongue: English
Weight: 118 KB
Volume: 34
Category: Article
ISSN: 0271-9142
DOI: 10.1007/s10875-014-0096-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and Safety of IgPro20, a 20% Im

Efficacy and Safety of IgPro20, a 20% Immunoglobulin for Subcutaneous Administration, in Patients with Primary Immunodeficiency Switching from Intravenous Replacement Therapy

✍ Stephen Jolles; Victor Cristea; Volker Wahn; Marianne Debré; Hilary Longhurst; O 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Evaluation of safety and efficacy of a 2

Evaluation of safety and efficacy of a 20% Subcutaneous Immunoglobulin (Hizentra™), after a dose equivalent switch from intravenous or subcutaneous replacement therapy in a cohort of primary immunodeficient patients

✍ Adriana Martin, Robert Schellenberg 📂 Article 📅 2012 🏛 BC Decker 🌐 English ⚖ 68 KB

Efficacy and safety of Hizentra® in pati

Efficacy and safety of Hizentra® in patients with primary immunodeficiency after a dose-equivalent switch from intravenous or subcutaneous replacement therapy

✍ S. Jolles; E. Bernatowska; J. de Gracia; M. Borte; V. Cristea; H.H. Peter; B.H. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 506 KB